目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 LAPAROSCOPIC INSTRUMENTS MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary data sources
2.1.1.2 Key sources of secondary data
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary data sources
2.1.2.2 Objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key industry insights
2.1.2.5 Breakdown of primaries
2.1.3 MARKET SIZE ESTIMATION
2.1.4 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
2.1.5 PARENT MARKET APPROACH
2.1.6 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.1.7 DEMAND-SIDE ANALYSIS
2.1.8 TOP-DOWN APPROACH (BASED ON UTILIZATION RATE AND ADOPTION PATTERN)
2.2 DATA TRIANGULATION
2.3 RESEARCH LIMITATIONS
2.3.1 SCOPE-RELATED LIMITATIONS
2.3.2 METHODOLOGY-RELATED LIMITATIONS
2.4 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 LAPAROSCOPIC INSTRUMENTS MARKET OVERVIEW
4.2 ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION AND USAGE
4.3 LAPAROSCOPIC INSTRUMENTS MARKET: GEOGRAPHIC MIX
4.4 LAPAROSCOPIC INSTRUMENTS MARKET: REGIONAL MIX
4.5 LAPAROSCOPIC INSTRUMENTS MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing adoption of minimally invasive surgeries over open surgeries
5.2.1.2 Rising adoption of single-use laparoscopic instruments
5.2.1.3 Growing prevalence of colorectal cancer
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable healthcare reforms
5.2.2.2 Dearth of trained professionals
5.2.3 OPPORTUNITIES
5.2.3.1 Improving healthcare markets in emerging economies
5.2.3.2 Technological advancements and innovations in laparoscopic instruments
5.2.4 CHALLENGES
5.2.4.1 Regulatory hurdles and compliance complexity
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 High-definition and 4K imaging systems
5.3.2 COMPLEMENTARY TECHNOLOGIES
5.3.2.1 Surgical navigation and imaging software
5.3.3 ADJACENT TECHNOLOGIES
5.3.3.1 Robotic surgical platforms
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 ROLE IN ECOSYSTEM
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE OF LAPAROSCOPIC INSTRUMENTS, BY KEY PLAYER, 2024
5.6.2 AVERAGE SELLING PRICE TREND OF LAPAROSCOPIC INSTRUMENTS, BY TYPE, 2022-2025
5.6.3 AVERAGE SELLING PRICE TREND OF LAPAROSCOPIC INSTRUMENTS, BY REGION, 2022-2024
5.7 SUPPLY CHAIN ANALYSIS
5.8 PORTER'S FIVE FORCES ANALYSIS
5.8.1 INTENSITY OF COMPETITIVE RIVALRY
5.8.2 BARGAINING POWER OF SUPPLIERS
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 THREAT OF SUBSTITUTES
5.8.5 THREAT OF NEW ENTRANTS
5.9 KEY STAKEHOLDERS & BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.9.2 KEY BUYING CRITERIA
5.10 REGULATORY ANALYSIS
5.10.1 REGULATORY LANDSCAPE
5.10.1.1 North America
5.10.1.1.1 US
5.10.1.1.2 Canada
5.10.1.2 Europe
5.10.1.3 Asia Pacific
5.10.1.3.1 Japan
5.10.1.3.2 China
5.10.1.3.3 India
5.10.1.4 Latin America
5.10.1.5 Middle East & Africa and GCC Countries
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA FOR HS CODE 300640, 2019-2023
5.11.2 EXPORT DATA FOR HS CODE 300640, 2019-2023
5.12 KEY CONFERENCES & EVENTS, 2025-2026
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.14 PATENT ANALYSIS
5.14.1 PATENT PUBLICATION TRENDS FOR LAPAROSCOPES
5.14.2 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR LAPAROSCOPIC INSTRUMENT PATENTS
5.14.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR LAPAROSCOPIC PATENTS
5.15 CASE STUDY ANALYSIS
5.15.1 ETHICON'S ENSEAL X1 TISSUE SEALER TO TREAT UTERINE FIBROIDS
5.15.2 AIR QUALITY TO IMPROVE IN LAPAROSCOPIC DISINFECTION UNITS WITH AIRSTERIL PHOTO-CATALYTIC AIR PURIFIERS
5.15.3 UV-C DISINFECTION SYSTEMS IN OPERATING THEATRES TO REDUCE HOSPITAL-ACQUIRED INFECTIONS
5.16 INVESTMENT & FUNDING SCENARIO
5.17 REIMBURSEMENT SCENARIO ANALYSIS
5.18 END-USER EXPECTATIONS
5.19 IMPACT OF AI/GEN AI ON LAPAROSCOPIC INSTRUMENTS MARKET
5.20 IMPACT OF 2025 US TARIFF ON LAPARSCOPIC INSTRUMENTS MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON END-USE INDUSTRIES

6 LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 LAPAROSCOPES
6.2.1 VIDEO LAPAROSCOPES
6.2.1.1 Delivery of brighter and higher-quality images of mucosal surface to propel adoption
6.2.2 FIBER LAPAROSCOPES
6.2.2.1 Affordability and operational simplicity to aid adoption in resource-limited environments and basic diagnostic procedures
6.3 ENERGY DEVICES
6.3.1 INCREASING DEMAND FOR REUSABLE MONOPOLAR AND BIPOLAR COAGULATION ENERGY DEVICES TO BOOST MARKET GROWTH
6.4 CLOSURE DEVICES
6.4.1 TECHNOLOGICAL ADVANCEMENTS AND PRODUCT INNOVATIONS TO FUEL MARKET GROWTH
6.5 HAND INSTRUMENTS
6.5.1 RISING NUMBER OF GENERAL LAPAROSCOPIC SURGERIES TO FAVOR MARKET GROWTH
6.6 ACCESS DEVICES
6.6.1 ACCESS DEVICES TO CREATE AND MAINTAIN PORTS OF ENTRANCE FOR OTHER INSTRUMENTS
6.7 ACCESSORIES
6.7.1 INCREASING SURGICAL VOLUMES TO SUPPORT MARKET GROWTH
6.8 INSUFFLATORS
6.8.1 RISING NUMBER OF LAPAROSCOPIC SURGERIES TO BOOST DEMAND FOR CO2 INSUFFLATORS
6.9 SUCTION/IRRIGATION SYSTEMS
6.9.1 POPULARITY OF INTEGRATED FLUID MANAGEMENT SYSTEMS FOR LAPAROSCOPIC PROCEDURES TO DRIVE MARKET

7 LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE
7.1 INTRODUCTION
7.2 REUSABLE LAPAROSCOPIC INSTRUMENTS
7.2.1 HIGH DURABILITY, COST-EFFECTIVENESS, AND BETTER COMPATIBILITY TO FUEL MARKET GROWTH
7.3 DISPOSABLE LAPAROSCOPIC INSTRUMENTS
7.3.1 RISING EMPHASIS ON INFECTION PREVENTION AND INCREASING NUMBER OF OUTPATIENT PROCEDURES TO PROPEL MARKET GROWTH

8 LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 GENERAL SURGERY
8.2.1 PREFERENCE FOR LAPAROSCOPY TECHNIQUES TO INCREASE FOR APPENDECTOMY, CHOLECYSTECTOMY, AND HERNIA REPAIR
8.3 GYNECOLOGICAL SURGERY
8.3.1 INCREASING DEMAND FOR MINIMALLY INVASIVE GYNECOLOGY SURGERIES TO DRIVE MARKET
8.4 COLORECTAL SURGERY
8.4.1 INCREASING INCIDENCE OF COLORECTAL CANCER TO AID MARKET GROWTH
8.5 BARIATRIC SURGERY
8.5.1 GROWING PREVALCENCE OF OBESITY TO AUGMENT MARKET GROWTH
8.6 UROLOGICAL SURGERY
8.6.1 INCREASING INCIDENCE OF CHRONIC UROLOGICAL DISEASES TO DRIVE MARKET
8.7 PEDIATRIC SURGERY
8.7.1 PREFERENCE FOR MINIMALLY INVASIVE TECHNIQUES IN TREATING CONGENITAL CONDITIONS IN CHILDREN TO BOOST MARKET GROWTH
8.8 OTHER APPLICATIONS

9 LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS & CLINICS
9.2.1 HIGH INVESTMENTS FROM GOVERNMENT BODIES AND PRIVATE INVESTORS TO DRIVE MARKET
9.3 AMBULATORY SURGICAL CENTERS
9.3.1 INCREASED ADOPTION OF OUTPATIENT SURGERIES TO BOOST MARKET GROWTH
9.4 OTHER END USERS

10 LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate global laparoscopic instruments market during forecast period
10.2.3 CANADA
10.2.3.1 Rising incidence of chronic diseases among geriatric population to fuel market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 High incidence of cancer and stroke to propel market growth
10.3.3 FRANCE
10.3.3.1 Favorable health insurance system and increased adoption of minimally invasive surgical procedures to boost market growth
10.3.4 UK
10.3.4.1 Implementation of National Bowel Cancer Screening Program by NHS to support adoption of laparoscopes
10.3.5 ITALY
10.3.5.1 Rising prevalence of colorectal cancer to boost market growth
10.3.6 SPAIN
10.3.6.1 Superior reimbursement scenario for hemodialysis procedures to augment market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Rapid growth in geriatric population and innovations in laparoscopic surgeries to fuel market growth
10.4.3 CHINA
10.4.3.1 Rising government healthcare spending to drive adoption of laparoscopic instruments
10.4.4 INDIA
10.4.4.1 Healthcare infrastructural improvements and implementation of favorable government initiatives to support market growth
10.4.5 AUSTRALIA
10.4.5.1 Increasing obesity rates and rising number of bariatric surgeries to aid market growth
10.4.6 SOUTH KOREA
10.4.6.1 High geriatric population and increased number of surgical procedures to propel market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 High demand for advanced surgical technologies to spur adoption of laparoscopic instruments
10.5.3 MEXICO
10.5.3.1 Increasing incidence of lifestyle-related disorders to augment market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Increasing incidence of lifestyle-related disorders and growing disposable income to favor market growth
10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN LAPAROSCOPIC INSTRUMENTS MARKET
11.3 REVENUE ANALYSIS, 2020-2024
11.4 MARKET SHARE ANALYSIS, 2024
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS 2024
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Product footprint
11.5.5.4 Application footprint
11.5.5.5 Usability footprint
11.5.5.6 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 DYNAMIC COMPANIES
11.6.3 RESPONSIVE COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.6.5.1 Detailed list of key startups/SMEs
11.6.5.2 Competitive benchmarking of startups/SMEs
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.7.3 R&D EXPENDITURE OF KEY PLAYERS, 2023 VS. 2024
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 EXPANSIONS

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 JOHNSON & JOHNSON
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 MEDTRONIC
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 OLYMPUS CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches
12.1.3.3.2 Deals
12.1.3.3.3 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 KARL STORZ SE & CO. KG
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 STRYKER
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches
12.1.5.3.2 Deals
12.1.5.3.3 Expansions
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 FUJIFILM HOLDINGS CORPORATION
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 HOYA CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.8 SMITH & NEPHEW
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.9 COOK
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches
12.1.10 B. BRAUN SE
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.11 VICTOR MEDICAL INSTRUMENTS CO., LTD.
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 ENDOMED SYSTEMS GMBH
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 SCHOLLY FIBEROPTIC GMBH
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.14 BOSTON SCIENTIFIC CORPORATION
12.1.14.1 Business overview
12.1.14.2 Products offered
12.2 OTHER PLAYERS
12.2.1 CONMED CORPORATION
12.2.2 CAPSOVISION, INC.
12.2.3 COOPERCOMPANIES
12.2.4 TELEFLEX INCORPORATED
12.2.5 CARL ZEISS AG
12.2.6 AMBU A/S
12.2.7 LABORIE
12.2.8 FORTIMEDIX SURGICAL
12.2.9 DANTSCHKE MEDIZINTECHNIK GMBH & CO. KG
12.2.10 MYELOTEC CO., LTD.
12.2.11 RICHARD WOLF GMBH
12.2.12 ZHEJIANG GEYI MEDICAL INSTRUMENT CO., LTD.

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS